aluates Reports

$ 0.0

Automative

Global Microbiome CDMO Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-25Y16223

Global Microbiome CDMO Market Research Report 2023

BUY CHAPTERS

Global Microbiome CDMO Market Research Report 2025

Code: QYRE-Auto-25Y16223

Report

May 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Arranta Bio

Wacker Chemie AG

Biose

Lallemand Health Solutions

Lonza

MaaT Pharma

NIZO

Recipharm

Bactera

SGS Quay Pharma

EnteroBiotix

Genome And Company

List Bio

Rise BioServices

Quay Pharmaceuticals

Microbiome CDMO Market Size

The global market for Microbiome CDMO was valued at US$ 1557 million in the year 2024 and is projected to reach a revised size of US$ 2969 million by 2031, growing at a CAGR of 9.8% during the forecast period.

Microbiome CDMO Market

Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.

With the continuous deepening of microbiome research, more and more companies and research institutions have begun to realize the application potential of microbiome in medicine, agriculture, food and other fields, which has brought huge market demand to the microbiome CDMO industry.

This report aims to provide a comprehensive presentation of the global market for Microbiome CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome CDMO.

The Microbiome CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microbiome CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microbiome CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microbiome CDMO Market Report

Report Metric	Details
Report Name	Microbiome CDMO Market
Accounted market size in year	US$ 1557 million
Forecasted market size in 2031	US$ 2969 million
CAGR	9.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Microbial CDMO Antibiotic CDMO Phage CDMO Bacteriocins CDMO
Segment by Application	Vaccine R&D Biopharmaceutical Cell Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Arranta Bio, Wacker Chemie AG, Bactera, SGS Quay Pharma, Biose, EnteroBiotix, Genome And Company, Lallemand Health Solutions, List Bio, Rise BioServices, Lonza, MaaT Pharma, NIZO, Quay Pharmaceuticals, Recipharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Microbiome CDMO Market growing?

Ans: The Microbiome CDMO Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Microbiome CDMO Market size in 2031?

Ans: The Microbiome CDMO Market size in 2031 will be US$ 2969 million.

Who are the main players in the Microbiome CDMO Market report?

Ans: The main players in the Microbiome CDMO Market are Arranta Bio, Wacker Chemie AG, Bactera, SGS Quay Pharma, Biose, EnteroBiotix, Genome And Company, Lallemand Health Solutions, List Bio, Rise BioServices, Lonza, MaaT Pharma, NIZO, Quay Pharmaceuticals, Recipharm

What are the Application segmentation covered in the Microbiome CDMO Market report?

Ans: The Applications covered in the Microbiome CDMO Market report are Vaccine R&D, Biopharmaceutical, Cell Therapy, Others

What are the Type segmentation covered in the Microbiome CDMO Market report?

Ans: The Types covered in the Microbiome CDMO Market report are Microbial CDMO, Antibiotic CDMO, Phage CDMO, Bacteriocins CDMO

Recommended Reports

Microbiome Applications

CDMO Services

CDMO Segments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microbiome CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Microbial CDMO

1.2.3 Antibiotic CDMO

1.2.4 Phage CDMO

1.2.5 Bacteriocins CDMO

1.3 Market by Application

1.3.1 Global Microbiome CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Vaccine R&D

1.3.3 Biopharmaceutical

1.3.4 Cell Therapy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microbiome CDMO Market Perspective (2020-2031)

2.2 Global Microbiome CDMO Growth Trends by Region

2.2.1 Global Microbiome CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Microbiome CDMO Historic Market Size by Region (2020-2025)

2.2.3 Microbiome CDMO Forecasted Market Size by Region (2026-2031)

2.3 Microbiome CDMO Market Dynamics

2.3.1 Microbiome CDMO Industry Trends

2.3.2 Microbiome CDMO Market Drivers

2.3.3 Microbiome CDMO Market Challenges

2.3.4 Microbiome CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microbiome CDMO Players by Revenue

3.1.1 Global Top Microbiome CDMO Players by Revenue (2020-2025)

3.1.2 Global Microbiome CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Microbiome CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Microbiome CDMO Revenue

3.4 Global Microbiome CDMO Market Concentration Ratio

3.4.1 Global Microbiome CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microbiome CDMO Revenue in 2024

3.5 Global Key Players of Microbiome CDMO Head office and Area Served

3.6 Global Key Players of Microbiome CDMO, Product and Application

3.7 Global Key Players of Microbiome CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome CDMO Breakdown Data by Type

4.1 Global Microbiome CDMO Historic Market Size by Type (2020-2025)

4.2 Global Microbiome CDMO Forecasted Market Size by Type (2026-2031)

5 Microbiome CDMO Breakdown Data by Application

5.1 Global Microbiome CDMO Historic Market Size by Application (2020-2025)

5.2 Global Microbiome CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Microbiome CDMO Market Size (2020-2031)

6.2 North America Microbiome CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Microbiome CDMO Market Size by Country (2020-2025)

6.4 North America Microbiome CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microbiome CDMO Market Size (2020-2031)

7.2 Europe Microbiome CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Microbiome CDMO Market Size by Country (2020-2025)

7.4 Europe Microbiome CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Microbiome CDMO Market Size (2020-2031)

8.2 Asia-Pacific Microbiome CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Microbiome CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Microbiome CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Microbiome CDMO Market Size (2020-2031)

9.2 Latin America Microbiome CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Microbiome CDMO Market Size by Country (2020-2025)

9.4 Latin America Microbiome CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microbiome CDMO Market Size (2020-2031)

10.2 Middle East & Africa Microbiome CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Microbiome CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Microbiome CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Arranta Bio

11.1.1 Arranta Bio Company Details

11.1.2 Arranta Bio Business Overview

11.1.3 Arranta Bio Microbiome CDMO Introduction

11.1.4 Arranta Bio Revenue in Microbiome CDMO Business (2020-2025)

11.1.5 Arranta Bio Recent Development

11.2 Wacker Chemie AG

11.2.1 Wacker Chemie AG Company Details

11.2.2 Wacker Chemie AG Business Overview

11.2.3 Wacker Chemie AG Microbiome CDMO Introduction

11.2.4 Wacker Chemie AG Revenue in Microbiome CDMO Business (2020-2025)

11.2.5 Wacker Chemie AG Recent Development

11.3 Bactera

11.3.1 Bactera Company Details

11.3.2 Bactera Business Overview

11.3.3 Bactera Microbiome CDMO Introduction

11.3.4 Bactera Revenue in Microbiome CDMO Business (2020-2025)

11.3.5 Bactera Recent Development

11.4 SGS Quay Pharma

11.4.1 SGS Quay Pharma Company Details

11.4.2 SGS Quay Pharma Business Overview

11.4.3 SGS Quay Pharma Microbiome CDMO Introduction

11.4.4 SGS Quay Pharma Revenue in Microbiome CDMO Business (2020-2025)

11.4.5 SGS Quay Pharma Recent Development

11.5 Biose

11.5.1 Biose Company Details

11.5.2 Biose Business Overview

11.5.3 Biose Microbiome CDMO Introduction

11.5.4 Biose Revenue in Microbiome CDMO Business (2020-2025)

11.5.5 Biose Recent Development

11.6 EnteroBiotix

11.6.1 EnteroBiotix Company Details

11.6.2 EnteroBiotix Business Overview

11.6.3 EnteroBiotix Microbiome CDMO Introduction

11.6.4 EnteroBiotix Revenue in Microbiome CDMO Business (2020-2025)

11.6.5 EnteroBiotix Recent Development

11.7 Genome And Company

11.7.1 Genome And Company Company Details

11.7.2 Genome And Company Business Overview

11.7.3 Genome And Company Microbiome CDMO Introduction

11.7.4 Genome And Company Revenue in Microbiome CDMO Business (2020-2025)

11.7.5 Genome And Company Recent Development

11.8 Lallemand Health Solutions

11.8.1 Lallemand Health Solutions Company Details

11.8.2 Lallemand Health Solutions Business Overview

11.8.3 Lallemand Health Solutions Microbiome CDMO Introduction

11.8.4 Lallemand Health Solutions Revenue in Microbiome CDMO Business (2020-2025)

11.8.5 Lallemand Health Solutions Recent Development

11.9 List Bio

11.9.1 List Bio Company Details

11.9.2 List Bio Business Overview

11.9.3 List Bio Microbiome CDMO Introduction

11.9.4 List Bio Revenue in Microbiome CDMO Business (2020-2025)

11.9.5 List Bio Recent Development

11.10 Rise BioServices

11.10.1 Rise BioServices Company Details

11.10.2 Rise BioServices Business Overview

11.10.3 Rise BioServices Microbiome CDMO Introduction

11.10.4 Rise BioServices Revenue in Microbiome CDMO Business (2020-2025)

11.10.5 Rise BioServices Recent Development

11.11 Lonza

11.11.1 Lonza Company Details

11.11.2 Lonza Business Overview

11.11.3 Lonza Microbiome CDMO Introduction

11.11.4 Lonza Revenue in Microbiome CDMO Business (2020-2025)

11.11.5 Lonza Recent Development

11.12 MaaT Pharma

11.12.1 MaaT Pharma Company Details

11.12.2 MaaT Pharma Business Overview

11.12.3 MaaT Pharma Microbiome CDMO Introduction

11.12.4 MaaT Pharma Revenue in Microbiome CDMO Business (2020-2025)

11.12.5 MaaT Pharma Recent Development

11.13 NIZO

11.13.1 NIZO Company Details

11.13.2 NIZO Business Overview

11.13.3 NIZO Microbiome CDMO Introduction

11.13.4 NIZO Revenue in Microbiome CDMO Business (2020-2025)

11.13.5 NIZO Recent Development

11.14 Quay Pharmaceuticals

11.14.1 Quay Pharmaceuticals Company Details

11.14.2 Quay Pharmaceuticals Business Overview

11.14.3 Quay Pharmaceuticals Microbiome CDMO Introduction

11.14.4 Quay Pharmaceuticals Revenue in Microbiome CDMO Business (2020-2025)

11.14.5 Quay Pharmaceuticals Recent Development

11.15 Recipharm

11.15.1 Recipharm Company Details

11.15.2 Recipharm Business Overview

11.15.3 Recipharm Microbiome CDMO Introduction

11.15.4 Recipharm Revenue in Microbiome CDMO Business (2020-2025)

11.15.5 Recipharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Arranta Bio

Wacker Chemie AG

Biose

Lallemand Health Solutions

Lonza

MaaT Pharma

NIZO

Recipharm

Bactera

SGS Quay Pharma

EnteroBiotix

Genome And Company

List Bio

Rise BioServices

Quay Pharmaceuticals

List of Tables

Table 1. Global Microbiome CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Microbial CDMO

Table 3. Key Players of Antibiotic CDMO

Table 4. Key Players of Phage CDMO

Table 5. Key Players of Bacteriocins CDMO

Table 6. Global Microbiome CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Microbiome CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Microbiome CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Microbiome CDMO Market Share by Region (2020-2025)

Table 10. Global Microbiome CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Microbiome CDMO Market Share by Region (2026-2031)

Table 12. Microbiome CDMO Market Trends

Table 13. Microbiome CDMO Market Drivers

Table 14. Microbiome CDMO Market Challenges

Table 15. Microbiome CDMO Market Restraints

Table 16. Global Microbiome CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Microbiome CDMO Market Share by Players (2020-2025)

Table 18. Global Top Microbiome CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome CDMO as of 2024)

Table 19. Ranking of Global Top Microbiome CDMO Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Microbiome CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Microbiome CDMO, Headquarters and Area Served

Table 22. Global Key Players of Microbiome CDMO, Product and Application

Table 23. Global Key Players of Microbiome CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Microbiome CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Microbiome CDMO Revenue Market Share by Type (2020-2025)

Table 27. Global Microbiome CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Microbiome CDMO Revenue Market Share by Type (2026-2031)

Table 29. Global Microbiome CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Microbiome CDMO Revenue Market Share by Application (2020-2025)

Table 31. Global Microbiome CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Microbiome CDMO Revenue Market Share by Application (2026-2031)

Table 33. North America Microbiome CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Microbiome CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Microbiome CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Microbiome CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Microbiome CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Microbiome CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Microbiome CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Microbiome CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Microbiome CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Microbiome CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Microbiome CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Microbiome CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Microbiome CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Microbiome CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Microbiome CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 48. Arranta Bio Company Details

Table 49. Arranta Bio Business Overview

Table 50. Arranta Bio Microbiome CDMO Product

Table 51. Arranta Bio Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 52. Arranta Bio Recent Development

Table 53. Wacker Chemie AG Company Details

Table 54. Wacker Chemie AG Business Overview

Table 55. Wacker Chemie AG Microbiome CDMO Product

Table 56. Wacker Chemie AG Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 57. Wacker Chemie AG Recent Development

Table 58. Bactera Company Details

Table 59. Bactera Business Overview

Table 60. Bactera Microbiome CDMO Product

Table 61. Bactera Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 62. Bactera Recent Development

Table 63. SGS Quay Pharma Company Details

Table 64. SGS Quay Pharma Business Overview

Table 65. SGS Quay Pharma Microbiome CDMO Product

Table 66. SGS Quay Pharma Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 67. SGS Quay Pharma Recent Development

Table 68. Biose Company Details

Table 69. Biose Business Overview

Table 70. Biose Microbiome CDMO Product

Table 71. Biose Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 72. Biose Recent Development

Table 73. EnteroBiotix Company Details

Table 74. EnteroBiotix Business Overview

Table 75. EnteroBiotix Microbiome CDMO Product

Table 76. EnteroBiotix Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 77. EnteroBiotix Recent Development

Table 78. Genome And Company Company Details

Table 79. Genome And Company Business Overview

Table 80. Genome And Company Microbiome CDMO Product

Table 81. Genome And Company Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 82. Genome And Company Recent Development

Table 83. Lallemand Health Solutions Company Details

Table 84. Lallemand Health Solutions Business Overview

Table 85. Lallemand Health Solutions Microbiome CDMO Product

Table 86. Lallemand Health Solutions Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 87. Lallemand Health Solutions Recent Development

Table 88. List Bio Company Details

Table 89. List Bio Business Overview

Table 90. List Bio Microbiome CDMO Product

Table 91. List Bio Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 92. List Bio Recent Development

Table 93. Rise BioServices Company Details

Table 94. Rise BioServices Business Overview

Table 95. Rise BioServices Microbiome CDMO Product

Table 96. Rise BioServices Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 97. Rise BioServices Recent Development

Table 98. Lonza Company Details

Table 99. Lonza Business Overview

Table 100. Lonza Microbiome CDMO Product

Table 101. Lonza Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 102. Lonza Recent Development

Table 103. MaaT Pharma Company Details

Table 104. MaaT Pharma Business Overview

Table 105. MaaT Pharma Microbiome CDMO Product

Table 106. MaaT Pharma Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 107. MaaT Pharma Recent Development

Table 108. NIZO Company Details

Table 109. NIZO Business Overview

Table 110. NIZO Microbiome CDMO Product

Table 111. NIZO Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 112. NIZO Recent Development

Table 113. Quay Pharmaceuticals Company Details

Table 114. Quay Pharmaceuticals Business Overview

Table 115. Quay Pharmaceuticals Microbiome CDMO Product

Table 116. Quay Pharmaceuticals Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 117. Quay Pharmaceuticals Recent Development

Table 118. Recipharm Company Details

Table 119. Recipharm Business Overview

Table 120. Recipharm Microbiome CDMO Product

Table 121. Recipharm Revenue in Microbiome CDMO Business (2020-2025) & (US$ Million)

Table 122. Recipharm Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Microbiome CDMO Picture

Figure 2. Global Microbiome CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Microbiome CDMO Market Share by Type: 2024 VS 2031

Figure 4. Microbial CDMO Features

Figure 5. Antibiotic CDMO Features

Figure 6. Phage CDMO Features

Figure 7. Bacteriocins CDMO Features

Figure 8. Global Microbiome CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Microbiome CDMO Market Share by Application: 2024 VS 2031

Figure 10. Vaccine R&D Case Studies

Figure 11. Biopharmaceutical Case Studies

Figure 12. Cell Therapy Case Studies

Figure 13. Others Case Studies

Figure 14. Microbiome CDMO Report Years Considered

Figure 15. Global Microbiome CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Microbiome CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Microbiome CDMO Market Share by Region: 2024 VS 2031

Figure 18. Global Microbiome CDMO Market Share by Players in 2024

Figure 19. Global Top Microbiome CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome CDMO as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Microbiome CDMO Revenue in 2024

Figure 21. North America Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Microbiome CDMO Market Share by Country (2020-2031)

Figure 23. United States Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Microbiome CDMO Market Share by Country (2020-2031)

Figure 27. Germany Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Microbiome CDMO Market Share by Region (2020-2031)

Figure 35. China Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Microbiome CDMO Market Share by Country (2020-2031)

Figure 43. Mexico Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Microbiome CDMO Market Share by Country (2020-2031)

Figure 47. Turkey Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Microbiome CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Arranta Bio Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 51. Wacker Chemie AG Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 52. Bactera Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 53. SGS Quay Pharma Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 54. Biose Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 55. EnteroBiotix Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 56. Genome And Company Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 57. Lallemand Health Solutions Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 58. List Bio Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 59. Rise BioServices Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 60. Lonza Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 61. MaaT Pharma Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 62. NIZO Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 63. Quay Pharmaceuticals Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 64. Recipharm Revenue Growth Rate in Microbiome CDMO Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Microbial Fermentation CDMO Services Market Research Report 2024

Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030

Global Biopharmaceutical and Bio CDMO Market Research Report 2024

Global Biopharmaceutical CDMO Market Research Report 2025

Global Biopharmaceutical CDMO Service Market Research Report 2024

Global Probiotics CDMO Service Market Research Report 2024

Global Biological Drug CDMO Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Biologics CDMO Market

Global Full Service CDMO Market Research Report 2024

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Global Biologics CDMO Services Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Microbial CDMO Service Market Research Report 2024

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

Global Plasmid DNA CDMO Service Market Research Report 2024

Global Formulation CDMO Services Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions